2016 / 06

Next Paper
DOI: 10.24075/brsmu.2016-06-02

ORIGINAL RESEARCH

Analysis of mildronate effect on the catalytic activity of cytochrome Р450 3А4

Kuzikov AV1,2, Bulko TV1, Masamrekh RA2, Makhova AA3, Archakov AI1,2, Usanov SA4, Shikh EV3, Shumyantseva VV1,2
About authors

1 Laboratory of Bioelectrochemistry, Department of Personalized Medicine,
Institute of Biomedical Chemistry, Moscow, Russia

2 Department of Biochemistry, Biomedical Faculty,
Pirogov Russian National Research Medical University, Moscow, Russia

3 Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Faculty of General Medicine,
I. M. Sechenov First Moscow State Medical University, Moscow, Russia

4 Institute of Bioorganic Chemistry of the National Academy of Sciences, Minsk, Republic of Belarus

Correspondence should be addressed: Victoria Shumyantseva
ul. Pogodinskaya, d. 10, Moscow, Russia, 119121; ur.liam@avestnaymuhs_v

About paper

Funding: this work was conducted under the Federal Fundamental Scientific Research Program for 2013–2020.

Received: 2016-11-28 Accepted: 2016-12-06 Published online: 2017-01-19
|
  1. Guengerich FP. Human Cytochrome P450 Enzymes. In: Ortiz de Montellano PR, editor. Cytochrome P450: Structure, Mechanism, and Biochemistry. San Francisco: Springer; 2015. p. 523–785.
  2. Hrycay EG, Bandiera SM. Involvement of Cytochrome P450 in Reactive Oxygen Species Formation and Cancer. Adv Pharmacol. 2015; 74: 35–84.
  3. Hrycay EG, Bandiera SM. The monooxygenase, peroxidase, and peroxygenase properties of cytochrome P450. Arch Biochem Biophys. 2012 Jun 15; 522 (2): 71–89.
  4. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013 Apr; 138 (1): 103–41.
  5. Nebert DW, Russel DW. Clinical importance of the cytochromes P450. Lancet. 2002 Oct 12; 360 (9340): 1155–62.
  6. Zhou SF, Xue CC, Yu XQ, Li C, Wang G. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit. 2007 Dec; 29 (6): 687–710.
  7. Hisaka A, Ohno Y, Yamamoto T, Suzuki H. Prediction of pharmacokinetic drug–drug interaction caused by changes in cytochrome P450 activity using in vivo information. Pharmacol Ther. 2010 Feb; 125 (2): 230–48.
  8. Zhang L, Reynolds KS, Zhao P, Huang SM. Drug interactions evaluation: an integrated part of risk assessment of therapeutics. Toxicol Appl Pharmacol. 2010 Mar; 243 (2): 134–45.
  9. Carrara S, Cavallini A, Erokhin V, De Micheli G. Multi-panel drugs detection in human serum for personalized therapy. Biosens Bioelectron. 2011 May 15; 26 (9): 3914–9.
  10. Schneider E, Clark DS. Cytochrome P450 (CYP) enzymes and the development of CYP biosensors. Biosens Bioelectron. 2013 Jan 15; 39 (1): 1–13.
  11. Rua F, Sadeghi SJ, Castrignanò S, Valetti F, Gilardi G. Electrochemistry of Canis familiaris cytochrome P450 2D15 with gold nanoparticles: An alternative to animal testing in drug discovery. Bioelectrochemistry. 2015 Oct; 105: 110–6.
  12. Panicco P, Dodhia VR, Fantuzzi A, Gilardi G. Enzyme-based amperometric platform to determine the polymorphic response in drug metabolism by cytochromes P450. Anal Chem. 2011 Mar 15; 83 (6): 2179–86.
  13. Shumyantseva VV, Bulko TV, Suprun EV, Chalenko YaM, Vagin MYu, Rudakov YuO, et al. Electrochemical investigations of cytochrome P450. Biochem Biophys Acta. 2011 Jan; 1814 (1): 94–101.
  14. Yarman A, Wollenberger U, Scheller FW. Sensors based on cytochrome P450 and CYP mimicking systems. Electrochim Acta. 2013; 110: 63–72.
  15. Fantuzzi A, Mak LH, Capria E, Dodhia V, Panicco P, Collins S, et al. A new standardized electrochemical array for drug metabolic profiling with human cytochromes P450. Anal Chem. 2011 May 15; 83 (10): 3831–9.
  16. The Protein Data Bank [база данных, Интернет]. Rutgers (NJ): the Research Collaboratory for Structural Bioinformatics; 2003– [про- цитировано 01.12.2016]. Доступно по: http://www.rcsb.org/
  17. PubChem [база данных, Интернет]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004– [процитировано 01.12.2016]. Доступно по: https://pubchem.ncbi.nlm.nih.gov/
  18. Shumyantseva VV, Makhova AA, Bulko TV, Kuzikov AV, Shich EV, Kukes VG, et al. Electrocatalytic cycle of P450 cytochromes: the protective and stimulating roles of antioxidants. RSC Adv. 2015; 5: 71306–13.
  19. Zadionchenko VS, Shekhyan GG, Yalymov AA, Asymbekova EU, Tugeeva EF, Sherstyannikova OM. Mesto mel'doniya v metabolicheskoi tsitoprotektsii. Russkii meditsinskii zhurnal. 2013; (9): 448–52. Russian.
  20. Mikhin VP, Pozdnyakov YuM, Khlebodarov FE, Koltsova ON. [Mildronate in cardiology practice — current evidence, ongoing research, and future perspectives]. Kardiovaskulyarnaya terapiya i profilaktika. 2012; 11 (1): 96–103. Russian.
  21. Statsenko ME, Turkina SV. Metabolicheskaya kardioprotektsiya
  22. Sadovnikova II. Kardioprotektory. Nedootsenennye vozmozhnosti.
  23. Samorodskaya IV. Mel'donii: obzor rezul'tatov issledovanii.
  24. Syrkin AL, Dobrovol'skii AV. Antiishemicheskie preparaty metabolicheskogo deistviya. Consilium Medicum. 2002; 4 (11):
  25. Shumyantseva VV, Makhova AA, Bulko TV, Bernhardt R,
  26. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J Biol Chem. 1964 Jul; 239: 2379–85.
  27. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J. 1953 Oct; 55 (3): 416–21.
  28. Sadeghi S, Ferrero S, Di Nardo G, Gilardi G. Drug–drug interactions and cooperative effects detected in electrochemically driven human cytochrome P450 3A4. Bioelectrochemistry. 2012 Aug; 86: 87–91.
  29. Baj-Rossi C, Müller C, von Mandach U, De Micheli G, Carrara S. Faradic Peaks Enhanced by Carbon Nanotubes in Microsomal Cytochrome P450 Electrodes. Electroanalysis. 2015; 27: 1507– 15.
  30. Makhova AA, Shumyantseva VV, Shich EV, Bulko TV, Kukes VG, Sizova OS, et al. Electroanalysis of cytochrome P450 3A4 catalytic properties with nanostructured electrodes: The influence of vitamins B group on diclofenac metabolism. BioNanoSci. 2011; 1: 46–52.
  31. Shumyantseva VV, Makhova AA, Bulko TV, Shich EV, Kukes VG, Usanov SA, et al. The effect of antioxidants on electrocatalytic activity of cytochrome P450 3A4. Biochem (Mosc) Suppl Ser B Biomed Chem. 2013; 7: 160–4.
  32. Kimura Y, Ito H, Ohnishi R, Hatano T. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem Toxicol. 2010 Jan; 48 (1): 429–35.